SCHEMBL19415420

SCHEMBL19415420

CC(O)[C@H](O[Si](C)(C)C(C)(C)C)c1cccc(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.36
DHFR P00374 2/20 0.36
ADRB2 P07550 2/20 0.35
ADRB1 P08588 2/20 0.35
ADRB3 P13945 2/20 0.35
SLC2A1 P11166 2/20 0.35
CASR P41180 1/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A2 P23975 2/20 0.34
ACP3 P15309 1/20 0.34
AOC3 Q16853 1/20 0.34
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
ITGA5 P08648 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CYP2C19 P33261 1/20 0.34
HRH1 P35367 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23192881 0.82 DHFR (0.44) DHFRCASRSLC6A4SLC6A2ACP3
SCHEMBL21976685 0.82 AOC3 (0.39) SLC6A4AOC3CYP2C19APLNRALDH1A1
SCHEMBL15951861 0.80 OPRM1 (0.36) DHFRADRB2SLC6A4AOC3OPRK1
SCHEMBL9063602 0.78 AOC3 (0.43) CYP2B6DHFRSLC6A4SLC6A2ACP3
SCHEMBL19415421 0.76 SLC6A2 (0.39) CYP2B6ADRB2ADRB1ADRB3SLC6A4
SCHEMBL8310048 0.76 MEN1 (0.41) CYP2B6ADRB2ADRB1ADRB3SLC6A4
SCHEMBL8310050 0.76 MEN1 (0.41) CYP2B6ADRB2ADRB1ADRB3SLC6A4
SCHEMBL7003007 0.75 AOC3 (0.43) DHFRSLC6A4SLC6A2AOC3OPRK1
SCHEMBL1198705 0.75 CYP2B6 (0.34) CYP2B6ADRB2ADRB1ADRB3SLC6A4
SCHEMBL7712823 0.74 ACP3 (0.34) CYP2B6DHFRADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2527314-B1 Process for preparation of phenyl carbamate derivatives BIO-PHARM SOLUTIONS CO LTD (KR) 2017-10-04 EP disclosed